Discontinued — last reported Q3 '25
Year-over-year, this metric declined by 100.0%, from $100.00K to $0.00. Over 4 years (FY 2021 to FY 2025), Share Buybacks shows a downward trend with a -19.2% CAGR.
High repurchases often signal management's confidence in the company's valuation or a strategy to improve earnings per share.
The cash outflow associated with the company buying back its own shares from the open market. This is a primary method f...
Common among mature, cash-generative companies; peers in the healthcare sector often balance this with R&D investment.
share_repurchases| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $2.50M | $8.31M | $8.87M | $219.00K | $24.37M | $32.99M | $30.19M | $6.84M | $19.54M | $5.95M | $10.25M | $10.34M | $6.38M | $6.07M | $6.36M | $100.00K | $0.00 | $8.28M | $0.00 | $0.00 |
| QoQ Change | — | +231.9% | +6.7% | -97.5% | >999% | +35.3% | -8.5% | -77.4% | +185.8% | -69.6% | +72.4% | +0.9% | -38.3% | -4.8% | +4.8% | -98.4% | -100.0% | — | -100.0% | — |
| YoY Change | — | — | — | — | +873.4% | +296.8% | +240.4% | >999% | -19.8% | -82.0% | -66.1% | +51.3% | -67.3% | +2.1% | -37.9% | -99.0% | -100.0% | +36.3% | -100.0% | -100.0% |